Integrinαvβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis

被引:347
作者
Eliceiri, BP
Klemke, R
Strömblad, S
Cheresh, DA
机构
[1] Scripps Res Inst, IMM 24, Dept Immunol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, IMM 24, Dept Vasc Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1083/jcb.140.5.1255
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Angiogenesis depends on growth factors and vascular cell adhesion events. Integrins and growth factors are capable of activating the ras/MAP kinase pathway in vitro, yet how these signals influence endothelial cells during angiogenesis is unknown. Upon initiation of angiogenesis with basic fibroblast growth factor (bFGF) on the chick chorioallantoic membrane (CAM), endothelial cell mitogen-activated protein (MAP) kinase (ERK) activity was detected as early as 5 min yet was sustained for at least 20 h. The initial wave of ERK activity (5-120 min) was refractory to integrin antagonists, whereas the sustained activity (4-20 h) depended on integrin alpha v beta 3, but not beta 1 integrins. Inhibition of MAP kinase kinase (MEK) during this sustained alpha v beta 3-dependent ERK signal blocked the formation of new blood vessels while not influencing preexisting blood vessels on the CAM. Inhibition of MEK also blocked growth factor induced migration but not adhesion of endothelial cells in vitro. Therefore, angiogenesis depends on sustained ERK activity regulated by the ligation state of both a growth factor receptor and integrin alpha v beta.
引用
收藏
页码:1255 / 1263
页数:9
相关论文
共 46 条
[1]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[2]   Transforming growth factor beta 1 inhibits mitogen-activated protein kinase induced by basic fibroblast growth factor in smooth muscle cells [J].
Berrou, E ;
FontenayRoupie, M ;
Quarck, R ;
McKenzie, FR ;
LevyToledano, S ;
Tobelem, G ;
Bryckaert, M .
BIOCHEMICAL JOURNAL, 1996, 316 :167-173
[3]   Induction of the angiogenic phenotype by Hox D3 [J].
Boudreau, N ;
Andrews, C ;
Srebrow, A ;
Ravanpay, A ;
Cheresh, DA .
JOURNAL OF CELL BIOLOGY, 1997, 139 (01) :257-264
[4]   IDENTIFICATION OF MULTIPLE EXTRACELLULAR SIGNAL-REGULATED KINASES (ERKS) WITH ANTIPEPTIDE ANTIBODIES [J].
BOULTON, TG ;
COBB, MH .
CELL REGULATION, 1991, 2 (05) :357-371
[5]   ERKS - A FAMILY OF PROTEIN-SERINE THREONINE KINASES THAT ARE ACTIVATED AND TYROSINE PHOSPHORYLATED IN RESPONSE TO INSULIN AND NGF [J].
BOULTON, TG ;
NYE, SH ;
ROBBINS, DJ ;
IP, NY ;
RADZIEJEWSKA, E ;
MORGENBESSER, SD ;
DEPINHO, RA ;
PANAYOTATOS, N ;
COBB, MH ;
YANCOPOULOS, GD .
CELL, 1991, 65 (04) :663-675
[6]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[7]   ANTIINTEGRIN ALPHA-V-BETA-3 BLOCKS HUMAN BREAST-CANCER GROWTH AND ANGIOGENESIS IN HUMAN SKIN [J].
BROOKS, PC ;
STROMBLAD, S ;
KLEMKE, R ;
VISSCHER, D ;
SARKAR, FH ;
CHERESH, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1815-1822
[8]   INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[9]   INTEGRIN (THE CSAT ANTIGEN) - FUNCTIONALITY REQUIRES OLIGOMERIC INTEGRITY [J].
BUCK, CA ;
SHEA, E ;
DUGGAN, K ;
HORWITZ, AF .
JOURNAL OF CELL BIOLOGY, 1986, 103 (06) :2421-2428
[10]   EPIDERMAL GROWTH-FACTOR REGULATES P21(RAS) THROUGH THE FORMATION OF A COMPLEX OF RECEPTOR, GRB2 ADAPTER PROTEIN, AND SOS NUCLEOTIDE EXCHANGE FACTOR [J].
BUDAY, L ;
DOWNWARD, J .
CELL, 1993, 73 (03) :611-620